TY  - JOUR
PY  - 2022//
TI  - Screening for anxiety in children and adolescents: US Preventive Services Task Force Recommendation Statement
JO  - JAMA journal of the American Medical Association
A1  - Mangione, Carol M.
A1  - Barry, Michael J.
A1  - Nicholson, Wanda K.
A1  - Cabana, Michael
A1  - Coker, Tumaini Rucker
A1  - Davidson, Karina W.
A1  - Davis, Esa M.
A1  - Donahue, Katrina E.
A1  - Jaén, Carlos Roberto
A1  - Kubik, Martha
A1  - Li, Li
A1  - Ogedegbe, Gbenga
A1  - Pbert, Lori
A1  - Ruiz, John M.
A1  - Silverstein, Michael
A1  - Stevermer, James
A1  - Wong, John B.
SP  - 1438
EP  - 1444
VL  - 328
IS  - 14
N2  - IMPORTANCE: Anxiety disorder, a common mental health condition in the US, comprises a group of related conditions characterized by excessive fear or worry that present as emotional and physical symptoms. The 2018-2019 National Survey of Children's Health found that 7.8% of children and adolescents aged 3 to 17 years had a current anxiety disorder. Anxiety disorders in childhood and adolescence are associated with an increased likelihood of a future anxiety disorder or depression. <br><br>OBJECTIVE: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for anxiety disorders in children and adolescents. This is a new recommendation. POPULATION: Children and adolescents 18 years or younger who do not have a diagnosed anxiety disorder or are not showing recognized signs or symptoms of anxiety.     EVIDENCE ASSESSMENT: The USPSTF concludes with moderate certainty that screening for anxiety in children and adolescents aged 8 to 18 years has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on screening for anxiety in children 7 years or younger.     RECOMMENDATION: The USPSTF recommends screening for anxiety in children and adolescents aged 8 to 18 years. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger. (I statement).<p />  <p>Language: en</p>
LA  - en
SN  - 0098-7484
UR  - http://dx.doi.org/10.1001/jama.2022.16936
ID  - ref1
ER  -